It’s been a busy and productive year here at MIT Technology Review. We published magazine issues on power, creativity, innovation, bodies, relationships, and security. We hosted 14 exclusive virtual conversations with our editors and outside experts in our subscriber-only series, Roundtables, and held two events on MIT’s campus. And we published hundreds of articles online,…
Alex Blackwood was working as a real estate investing associate at Goldman Sachs. Here’s why he decided to start a business instead — despite the pay cut.
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology. The new company, called Preventive, is being formed to research so-called “heritable genome editing,” in which the DNA of embryos would be…